Precipio Inc (PRPO)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
$19.57+5.10%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
QuarterlyIQ Insights · PRPO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 27.2 | 24.0 | 18.5 | 15.2 | 9.4 | 8.8 | 6.1 | 3.1 | 2.9 | 1.7 | 1.6 | 1.9 | 1.2 | 27.5 | 31.5 | 32.0 |
| Total Revenues | 27.2 | 24.0 | 18.5 | 15.2 | 9.4 | 8.8 | 6.1 | 3.1 | 2.9 | 1.7 | 1.6 | 1.9 | 1.2 | 27.5 | 31.5 | 32.0 |
| Cost of Revenues | 15.2 | 13.3 | 11.0 | 9.2 | 6.9 | 6.5 | 4.9 | 2.9 | 2.6 | 1.4 | 1.0 | 1.9 | 2.2 | 16.8 | 18.3 | 13.5 |
| Gross Profit | 12.0 | 10.7 | 7.6 | 6.0 | 2.5 | 2.4 | 1.2 | 0.2 | 0.2 | 0.3 | 0.8 | (0.0) | (0.9) | 10.8 | 13.1 | 18.4 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | 10.3 | 9.6 | 9.5 | 6.5 | 2.5 | 7.1 | 7.4 | 23.3 | 20.1 | 19.2 |
| R&D Expenses | — | 1.6 | 1.3 | 1.7 | 1.7 | 1.3 | 1.2 | 1.2 | 1.1 | 0.5 | 0.0 | 1.9 | 2.2 | 3.2 | 2.5 | 2.2 |
| Operating Income | (1.5) | (1.2) | (4.2) | (7.6) | (12.8) | (9.6) | (9.1) | (11.0) | (13.9) | (15.5) | (1.7) | (8.9) | (10.6) | (15.8) | (9.5) | (3.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| EBT, Incl. Unusual Items | (1.2) | (0.4) | (4.3) | (5.9) | (12.2) | (8.5) | (10.6) | (13.3) | (16.0) | (20.7) | (2.2) | (9.9) | (10.8) | (16.0) | (8.2) | (9.7) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | (0.1) | (0.3) | — | 0.0 | 0.0 | 0.0 | (0.1) | 0.1 | 0.0 |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Income | — | (0.4) | (4.3) | (5.9) | (12.2) | (8.5) | (10.6) | (13.2) | (15.7) | (20.7) | (2.2) | (33.0) | (13.9) | (16.0) | (8.3) | (9.8) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.23) | (2.93) | (4.51) | (10.73) | (0.40) | (0.85) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | — | (0.23) | (2.93) | (4.51) | (10.73) | (0.40) | (0.85) | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 15.22 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 1.8 | 1.6 | 1.5 | 1.3 | 1.1 | 21.1 | 16.5 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 1.8 | 1.6 | 1.5 | 1.3 | 1.1 | 21.1 | 16.5 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 0.0 | (3.0) | (6.4) | (11.6) | (8.5) | (8.1) | (9.9) | (12.6) | (14.8) | (1.6) | (8.4) | (10.0) | (13.0) | (7.2) | (0.9) |
| EBIT | (1.5) | (1.2) | (4.2) | (7.6) | (12.8) | (9.6) | (9.1) | (11.0) | (13.9) | (15.5) | (1.7) | (8.9) | (10.6) | (15.8) | (9.5) | (3.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% | 1.7% | — | 0.0% | 0.0% | 0.0% | 0.3% | -1.8% | -0.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.